Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 626320, 10 pages
http://dx.doi.org/10.1155/2012/626320
Research Article

Classification of Traditional Chinese Medicine Syndromes in Patients with Chronic Hepatitis B by SELDI-Based ProteinChip Analysis

1Research Center for Traditional Chinese Medicine Complexity System, Shanghai University of Traditional Chinese Medicine,1200 Cailun Road, Pudong, Shanghai 201203, China
2Institute of Liver Diseases, Shuguang Hospital, Key Laboratory of Liver and Kidney Diseases of Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China

Received 12 January 2012; Accepted 28 March 2012

Academic Editor: Shao Li

Copyright © 2012 Ya-Nan Song et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Y. Jiang, “Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science,” Trends in Pharmacological Sciences, vol. 26, no. 11, pp. 558–563, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Liu, P. Liu, R. Dai et al., “Analysis of plasma proteome from cases of the different traditional Chinese medicine syndromes in patients with chronic hepatitis B,” Journal of Pharmaceutical and Biomedical Analysis, vol. 59, no. 1, pp. 173–178, 2012. View at Publisher · View at Google Scholar
  3. W. Xu, L. Q. Su, and H. J. Li, “Research advances and clinical evaluation of drugs for hepatitis B,” Chinese Journal of Hospital Pharmacy, vol. 28, no. 9, pp. 737–739, 2008. View at Google Scholar
  4. A. P. Lu, H. W. Jia, C. Xiao, and Q. P. Lu, “Theory of traditional chinese medicine and therapeutic method of diseases,” World Journal of Gastroenterology, vol. 10, no. 13, pp. 1854–1856, 2004. View at Google Scholar · View at Scopus
  5. A. Zuberovic, M. Wetterhall, J. Hanrieder, and J. Bergquist, “CE MALDI-TOF/TOF MS for multiplexed quantification of proteins in human ventricular cerebrospinal fluid,” Electrophoresis, vol. 30, no. 10, pp. 1836–1843, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Johannesson, L. Olsson, D. Bäckström, M. Wetterhall, R. Danielsson, and J. Bergquist, “Screening for biomarkers in plasma from patients with gangrenous and phlegmonous appendicitis using CE and CEC in combination with MS,” Electrophoresis, vol. 28, no. 9, pp. 1435–1443, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R. K. T. Kam, T. C. W. Poon, H. L. Y. Chan, N. Wong, A. Y. Hui, and J. J. Y. Sung, “High-throughput quantitative profiling of serum N-glycome by MALDI-TOF mass spectrometry and N-glycomic fingerprint of liver fibrosis,” Clinical Chemistry, vol. 53, no. 7, pp. 1254–1263, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Zhou, H. Li, D. DeCamp et al., “2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers.,” Molecular & Cellular Proteomics, vol. 1, no. 2, pp. 117–124, 2002. View at Google Scholar · View at Scopus
  9. T. W. Hutchens and T. T. Yip, “New desorption strategies for the mass- spectrometric analysis of macromolecules,” Rapid Communications in Mass Spectrometry, vol. 7, no. 7, pp. 576–580, 1993. View at Google Scholar
  10. L. Chen, D. W. Y. Ho, N. P. Y. Lee et al., “Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker,” Annals of Surgical Oncology, vol. 17, no. 9, pp. 2518–2525, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Liu, C. Pan, H. Wang, and L. Yong, “Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifying biomarkers of laryngeal carcinoma,” Tumor Biology, pp. 1–7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Fujita, M. Nakanishi, J. Mukai et al., “Identification of treatment efficacy-related host factors in chronic hepatitis C by proteinchip serum analysis,” Molecular Medicine, vol. 17, no. 1-2, pp. 70–78, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. W. F. Leemans, H. L. A. Janssen, and R. A. de Man, “Future prospectives for the management of chronic hepatitis B,” World Journal of Gastroenterology, vol. 13, no. 18, pp. 2554–2567, 2007. View at Google Scholar · View at Scopus
  14. D. Lavanchy, “Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention,” Journal of Clinical Virology, vol. 34, no. 1, pp. S1–S3, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. D. C. Valla, R. De Franchis, A. Hadengue et al., “EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version),” Journal of Hepatology, vol. 39, no. S1, pp. S3–S25, 2003. View at Google Scholar
  16. S. L. Wang, N. L. Yao, and W. L. Lv, “Advances in studies on effect superiorities of traditional Chinese medicine on chronic hepatitis B,” China Journal of Chinese Materia Medicasource, vol. 32, no. 23, pp. 2468–2470, 2007. View at Google Scholar · View at Scopus
  17. L. L. Tang, J. F. Sheng, C. H. Xu, and K. Z. Liu, “Clinical and experimental effectiveness of Astragali compound in the treatment of chronic viral hepatitis B,” Journal of International Medical Research, vol. 37, no. 3, pp. 662–667, 2009. View at Google Scholar · View at Scopus
  18. B. E. Wang, “Treatment of chronic liver diseases with traditional Chinese medicine,” Journal of Gastroenterology and Hepatology, vol. 15, pp. E67–E70, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Guide to Prevention and Treatment of Chronic Hepatitis B, 2005.
  20. “The standards of TCM differential syndromes of viral hepatitis,” Defined in December 1991 by Internal Medicine Hepatopathy Committee of Chinese Traditional Medicine Association.
  21. C. J. Hogeboom, K. J. Sherman, and D. C. Cherkin, “Variation in diagnosis and treatment of chronic low back pain by traditional Chinese medicine acupuncturists,” Complementary Therapies in Medicine, vol. 9, no. 3, pp. 154–166, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Zell, J. Hirata, A. Marcus, B. Ettinger, A. Pressman, and K. M. Ettinger, “Diagnosis of symptomatic postmenopausal women by traditional Chinese medicine practitioners,” Menopause, vol. 7, no. 2, pp. 129–134, 2000. View at Google Scholar · View at Scopus
  23. J. F. Cui, Y. K. Liu, H. J. Zhou et al., “Screening serum hepatocellular carcinoma-associated proteins by SELDI-based protein spectrum analysis,” World Journal of Gastroenterology, vol. 14, no. 8, pp. 1257–1262, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Matsumoto, T. Kojima, K. Ogawa et al., “A proteomic approach for the diagnosis of 'Oketsu' (blood stasis), a pathophysiologic concept of Japanese traditional (Kampo) medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 4, pp. 463–474, 2008. View at Publisher · View at Google Scholar · View at Scopus